Should metformin remain the first-line therapy for treatment of type 2 diabetes?
C Baker, C Retzik-Stahr, V Singh… - Therapeutic …, 2021 - journals.sagepub.com
Metformin is a biguanide that is used as first-line treatment of type 2 diabetes mellitus and is
effective as monotherapy and in combination with other glucose-lowering medications. It is …
effective as monotherapy and in combination with other glucose-lowering medications. It is …
AstraZeneca to showcase leadership in treating type-2 diabetes and cardiorenal complications at ADA 2020 (Cision)
T Avanza - placera.se
Exploratory analysis from Farxiga DAPA-HF Phase III trial will provide insights on the onset
of type-2 diabetes in heart failure patients Sub-analysis from the DECLARE Phase III trial to …
of type-2 diabetes in heart failure patients Sub-analysis from the DECLARE Phase III trial to …
AstraZeneca to showcase leadership in treating type-2 diabetes and cardiorenal complications at ADA 2020
COPM Robertson, CPPS Robertson, EO Blood… - mfn.se
AstraZeneca will present new data from the landmark Phase III DAPA-HF and DECLARE-
TIMI 58 trials at the upcoming 80 [th] American Diabetes Association (ADA) Virtual Scientific …
TIMI 58 trials at the upcoming 80 [th] American Diabetes Association (ADA) Virtual Scientific …
[PDF][PDF] Nationale VersorgungsLeitlinie
K Bundesvereinigung - 2021 - awmf.org
2 Zielsetzung Die hohe Prävalenz und Inzidenz des Asthmas in Deutschland sowie eine
große Variationsbreite in der Versorgungsqualität verlangen verstärkte Bemühungen um die …
große Variationsbreite in der Versorgungsqualität verlangen verstärkte Bemühungen um die …